Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.

Ashida, Atsuko; Sakaizawa, Kaori; Uhara, Hisashi; Okuyama, Ryuhei

Ashida, Atsuko; Sakaizawa, Kaori; Uhara, Hisashi; Okuyama, Ryuhei.

Affiliation

Ashida A; Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.

Acta Derm Venereol ; 97(10): 1212-1218, 2017 Nov 15.

Article in En | MEDLINE | ID: mdl-28681063

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents, Immunological/therapeutic use; Biomarkers, Tumor/blood; Cell-Free Nucleic Acids/genetics; Circulating Tumor DNA/blood; Drug Monitoring/methods; Immunotherapy/methods; Melanoma/drug therapy; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Skin Neoplasms/drug therapy; Aged; Aged, 80 and over; Biomarkers, Tumor/genetics; Cell Line, Tumor; Cell-Free Nucleic Acids/blood; Circulating Tumor DNA/genetics; DNA Mutational Analysis; Female; Humans; Male; Melanoma/blood; Melanoma/genetics; Melanoma/immunology; Middle Aged; Mutation; Nivolumab; Predictive Value of Tests; Programmed Cell Death 1 Receptor/immunology; Proto-Oncogene Proteins B-raf/genetics; Proto-Oncogene Proteins p21(ras)/genetics; Skin Neoplasms/blood; Skin Neoplasms/genetics; Skin Neoplasms/immunology; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Biomarkers, Tumor / Drug Monitoring / Programmed Cell Death 1 Receptor / Cell-Free Nucleic Acids / Circulating Tumor DNA / Antineoplastic Agents, Immunological / Immunotherapy / Melanoma / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Acta Derm Venereol Year: 2017 Document type: Article Affiliation country: Japan Country of publication: Sweden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google